KLRA
insider transactionsKailera Therapeutics, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Cluster buy signal: Multiple insiders at the same company buying around the same time — often a stronger signal than a single buy. 5 different insiders made open-market purchases in the last 90 days, totalling $326.8M.
Net shares · 90d
+20.4M
20.4M buy · 0 sell
Net value · 90d
$326.8M
$326.8M in · $0 out
Sentiment · 90d
Net buying
100% buying · 0% selling
Open-market trades · 90d
5
20.4M buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·M
CEO & President
$0
38.1K sh
Own +5%
-
Exercise·M
CEO & President
$200.0K
38.1K sh · $5.25
Own New
-
Exercise·C
Director, 10% Owner
$0
4.1M sh
Own New
-
Exercise·C
Director, 10% Owner
$0
16.9M sh
Own New
-
Buy·P
Director, 10% Owner
$25.0M
1.6M sh · $16.00
Own +7%
-
Exercise·C
Director, 10% Owner
—
4.1M sh
Own +25%
-
Exercise·C
Director, 10% Owner
—
16.9M sh
Own New
-
Exercise·C
Director, 10% Owner
$0
17.9M sh
Own New
-
Buy·P
Director, 10% Owner
$134.4M
8.4M sh · $16.00
Own +47%
-
Exercise·C
Director, 10% Owner
—
17.9M sh
Own New
-
Exercise·C
-
Exercise·C
-
Buy·P
-
Exercise·C
-
Exercise·C
-
Exercise·C
-
Buy·P
$134.4M
8.4M sh · $16.00
Own +47%
-
Exercise·C
-
Exercise·C
RTW INVESTMENTS, LP / Roderick Wong
10% Owner
—
2.0M sh
Own New
-
Exercise·C
RTW INVESTMENTS, LP / Roderick Wong
10% Owner
—
8.2M sh
Own New
-
Buy·P
RTW INVESTMENTS, LP / Roderick Wong
10% Owner
$8.0M
500.0K sh · $16.00
Own +5%
-
Exercise·C
RTW INVESTMENTS, LP / Roderick Wong
10% Owner
—
10.3M sh
Own New
-
Exercise·C
$0
708.8K sh
Own New
-
Exercise·C
$0
5.0M sh
Own New
-
Exercise·C
—
2.0M sh
Own New
-
Exercise·C
—
9.5M sh
Own New
-
Grant·A
Director, 10% Owner
$0
38.3K sh
Own New
-
Grant·A
Director, 10% Owner
$0
38.3K sh
Own New
-
Grant·A
CEO & President
$0
300.0K sh
Own New
-
Grant·A
Director
$0
38.3K sh
Own New
-
Grant·A
Director
$0
38.3K sh
Own New
-
Grant·A
Chief Medical Officer
$0
100.0K sh
Own New
-
Grant·A
Douglas W. Pagan KEY
Chief Financial Officer
$0
100.0K sh
Own New
-
Grant·A
Chief Commercial Officer
$0
75.0K sh
Own New
-
Grant·A
Director
$0
38.3K sh
Own New
-
Grant·A
Chief People Officer
$0
60.0K sh
Own New
-
Grant·A
Chief Operating Officer & Chi…
$0
100.0K sh
Own New
-
Grant·A
Chief Legal Officer
$0
60.0K sh
Own New
About KLRA insider trading
This page tracks insider transactions for Kailera Therapeutics, Inc. (KLRA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.